In silico study and cytotoxicity of the synthesized open-chain analogues of antimycin A₃ against HEP-2 laryngeal cancer cells

Keyphrases

• Cytotoxicity 100%
• Open Chain 100%
• In Silico Study 100%
• HEp-2 100%
• Laryngeal Cancer Cell 100%
• Antimycin A3 100%
• Laryngeal Cancer 57%
• B-cell Lymphoma 2 (Bcl-2) 28%
• Induced Apoptosis 14%
• Good Yield 14%
• IC50 14%
• Chemotherapy 14%
• Head-and-neck Cancer 14%
• Cytotoxic Activity 14%
• Threonine 14%
• HepG2 Cells 14%
• Cancer Drugs 14%
• Anticancer Activity 14%
• Cancer Chemotherapy 14%
• Esterification 14%
• Drug Resistance 14%
• Receptor Binding 14%
• Anti-apoptotic Bcl-2 14%
• Sharpless Asymmetric Dihydroxylation 14%
• Laryngeal Carcinoma 14%
• Cancer Agent 14%
• Amidation 14%
• Binding Targets 14%

Medicine and Dentistry

• Cancer Cell 100%
• Cytotoxicity 100%
• In Silico 100%
• Laryngeal Cancer 100%
• Citrinin 100%
• IC50 12%
• Head and Neck Cancer 12%
• Programmed Cell Death 12%
• Drug Resistance 12%
• Antiapoptotic 12%
• Antineoplastic Activity 12%
• Cancer Chemotherapy 12%
• Threonine 12%
• Larynx Carcinoma 12%
• Carcinogen 12%
• Receptor Binding 12%
• Dihydroxylation 12%
• Chemotherapy 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Larynx Cancer 100%
• Citrinin 100%
• Cytotoxicity 100%
• IC50 14%
• Chemotherapy 14%
• Receptor 14%
• Antiapoptotic 14%
• Head and Neck Cancer 14%
• Drug Resistance 14%
• Carcinogen 14%
• Threonine 14%
• Cancer Chemotherapy 14%
• Larynx Carcinoma 14%